Table: Daito - 6-MTH group results

Daito Pharmaceutical

14/01/2022 06:00

Jan 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Nov 30, 2021        Nov 30, 2020     May 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             22.46               26.04            42.50    
                                     (+12.0 pct)      (+6.2 pct)  
  Operating          3.88                3.51             5.90    
                 (+10.4 pct)         (+24.1 pct)      (-0.1 pct)  
  Recurring          3.98                3.56             6.00    
                 (+12.0 pct)         (+23.6 pct)      (-1.1 pct)  
  Net                2.78                2.42             4.25    
                 (+14.6 pct)         (+21.0 pct)      (+0.1 pct)  
  EPS            202.05 yen          178.30 yen       309.91 yen  
  Ann Div                             46.00 yen        50.00 yen  
  -Q2 div         25.00 yen           23.00 yen                   
  -Q4 div                             23.00 yen        25.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T